retatrutide glucagon receptor More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and receptors In the Phase retatrutide glucagon receptor agonist The
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15

























![Obelisk Spider [Mystery Booster] SPA Panacea](https://cdn.shopify.com/s/files/1/0268/5285/1798/files/da6a72f9-25c7-5550-835a-af5807896ec6.jpg?v=1768427667)